BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 20, 2007
View Archived Issues
Vinorelbine-cisplatin confirmed superior in stage II-IIIA NSCLC / News in Context
Read More
Eisai: Q3 report
Read More
Recent patents report new therapeutic agents for metabolic disorders
Read More
Recent Nissan Chemical patents describe new treatment options for thrombocytopenia
Read More
Axcan updates Q1 developments
Read More
ZymoGenetics' rhThrombin BLA accepted for review
Read More
SGX reviews oncology pipeline
Read More
Ark Therapeutics discusses phase III Vitor study with regulatory agencies
Read More
Valeant acquires rights to nabilone in the U.K. and Europe
Read More
KeyNeurotek and Max-Planck sign licensing agreement
Read More
Merck begins registrations of Atripla in developing countries
Read More
Inspire to commercialize AzaSite in U.S. and Canada
Read More
Gestiva reduces cervical shortening
Read More
Canarypox HIV vaccine responses in phase II not sufficient for phase III investigation
Read More
Pipex Pharmaceuticals' Coprexa awarded NIH grant for Alzheimer's disease
Read More
Post hoc subgroup analysis for Chrysalin in fracture repair
Read More
Safety, absorption of TMC-120 assessed in women with and without HIV
Read More
Traditional Chinese preparation to enter the clinic for the treatment of allergic asthma
Read More
New agents for treating neurological disorders disclosed in recent patents
Read More
Recent patents disclose novel treatments for diabetes
Read More
Cadherin-11: a potential target against rheumatoid arthritis
Read More
Cognitive and mood improvement after guarana therapy reported
Read More